Journal articleLancet Gastroenterol Hepatol2018
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial.
- Journal
- Lancet Gastroenterol Hepatol
- Published
- 4 April 2018
- Citations
- 207
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- Builds on itGemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer NCT01150630↗
- BackgroundLaparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC NCT04855331↗
- BackgroundShort-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) NCT04793932↗